Kate Sandstrom

557 total citations
13 papers, 435 citations indexed

About

Kate Sandstrom is a scholar working on Oncology, Immunology and Biotechnology. According to data from OpenAlex, Kate Sandstrom has authored 13 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 3 papers in Biotechnology. Recurrent topics in Kate Sandstrom's work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Research and Treatments (3 papers). Kate Sandstrom is often cited by papers focused on CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Research and Treatments (3 papers). Kate Sandstrom collaborates with scholars based in United States, Switzerland and Croatia. Kate Sandstrom's co-authors include Ronald M. Bukowski, Thomas Olencki, Robert J. Motzer, R Nadeau, Lawrence H. Schwartz, Ashok Rakhit, Hema Parmar, Denise McLain, James H. Finke and Paul Elson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Kate Sandstrom

13 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate Sandstrom United States	9	256	221	99	93	46	13	435
Arthur S. Centeno United States	6	283 1.1×	284 1.3×	114 1.2×	230 2.5×	31 0.7×	7	471
Sheri McMahon United States	10	299 1.2×	347 1.6×	108 1.1×	71 0.8×	54 1.2×	31	478
Neysa Garner United States	2	210 0.8×	392 1.8×	103 1.0×	102 1.1×	36 0.8×	2	529
K G Schepers United States	6	330 1.3×	421 1.9×	110 1.1×	44 0.5×	56 1.2×	7	624
Joanne Coleman United States	4	304 1.2×	362 1.6×	107 1.1×	63 0.7×	49 1.1×	6	573
Jean-Pascal H. Machiels United States	5	368 1.4×	435 2.0×	141 1.4×	185 2.0×	27 0.6×	7	702
Jackie Hernandez United States	5	185 0.7×	201 0.9×	77 0.8×	101 1.1×	19 0.4×	5	365
Arnold Baars Netherlands	11	356 1.4×	363 1.6×	189 1.9×	47 0.5×	21 0.5×	23	592
María Vela Spain	12	295 1.2×	319 1.4×	118 1.2×	40 0.4×	61 1.3×	24	488
Ainara Soria Spain	12	134 0.5×	336 1.5×	121 1.2×	133 1.4×	24 0.5×	46	505

Countries citing papers authored by Kate Sandstrom

Since Specialization

Citations

This map shows the geographic impact of Kate Sandstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Sandstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Sandstrom more than expected).

Fields of papers citing papers by Kate Sandstrom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Sandstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Sandstrom. The network helps show where Kate Sandstrom may publish in the future.

Co-authorship network of co-authors of Kate Sandstrom

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Sandstrom. A scholar is included among the top collaborators of Kate Sandstrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Sandstrom. Kate Sandstrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Grubb, William, Lee Ponsky, Simon S. Lo, et al.. (2020). Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. Radiotherapy and Oncology. 155. 138–143. 30 indexed citations

Mazanec, Susan R., Jennifer A. Dorth, Kate Sandstrom, et al.. (2020). Use of simulation for training family caregivers of patients receiving radiation therapy.. Journal of Clinical Oncology. 38(15_suppl). TPS12129–TPS12129. 1 indexed citations

Sandstrom, Kate, Paul Elson, Denise McLain, et al.. (2001). GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial. Journal of Cancer Research and Clinical Oncology. 127(10). 619–624. 4 indexed citations

Chidiac, Tarek, G. Thomas Budd, Robert Pelley, et al.. (2000). Phase II Trial of Liposomal Doxorubicin (Doxil®) in Advanced Soft Tissue Sarcomas. Investigational New Drugs. 18(3). 253–259. 39 indexed citations

Plautz, Gregory E., Ronald M. Bukowski, Andrew C. Novick, et al.. (1999). T-cell adoptive immunotherapy of metastatic renal cell carcinoma. Urology. 54(4). 617–623. 33 indexed citations

Plautz, Gregory E., Ronald M. Bukowski, Andrew C. Novick, et al.. (1999). T CELL ADOPTIVE IMMUNOTHERAPY OF METASTATIC RENAL CELL CARCINOMA. The Journal of Urology. 167–167. 1 indexed citations

Motzer, Robert J., Ashok Rakhit, Lawrence H. Schwartz, et al.. (1998). Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.. PubMed. 4(5). 1183–91. 194 indexed citations

Bukowski, Ronald M., Patricia Rayman, Robert G. Uzzo, et al.. (1998). Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.. PubMed. 4(10). 2337–47. 49 indexed citations

Bukowski, Ronald M., Thomas Olencki, David M. Peereboom, et al.. (1997). Phase II Trial of Interleukin-2 and Interferon-ce in Patients with Renal Cell Carcinoma: Clinical Results and Immunologic Correlates of Response. Journal of Immunotherapy. 20(4). 301–311. 28 indexed citations

10.

Tuason, Laurie, G. Thomas Budd, D. Peereboom, et al.. (1996). Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma.. PubMed. 77(6). 1149–53. 23 indexed citations

11.

Wos, Edward J., Thomas Olencki, Laurie Tuason, et al.. (1996). Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma. Cancer. 77(6). 1149–1153. 19 indexed citations

12.

Bukowski, Ronald M., Thomas Olencki, H Gunn, et al.. (1996). Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.. PubMed. 2(2). 347–57. 9 indexed citations

13.

Thomassen, Mary Jane, Joyce Antal, Mary J. Connors, et al.. (1993). Immunomodulatory Effects of Recombinant Interleukin-3 Treatment on Human Alveolar Macrophages and Monocytes. Journal of Immunotherapy. 14(1). 43–56. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact